General

HIQA reviewing metabolic surgery as treatment for Type 2 diabetes and obesity

HIQA has commenced work on a health technology assessment (HTA) of metabolic surgery for the treatment of type 2 diabetes (T2D) and obesity.

HIQA older people ionising

The Health Information and Quality Authority (HIQA) has commenced work on a health technology assessment (HTA) of metabolic surgery for the treatment of type 2 diabetes (T2D) and obesity.

Bariatric surgery involves modifying the stomach and intestines to treat obesity. The term metabolic surgery refers to the use of these surgical procedures in the treatment of metabolic diseases. Such as type 2 diabetes. A number of international diabetes associations, including the American Diabetes Association (ADA) and the International Diabetes Federation (IDF), recommend inclusion of metabolic surgery in the clinical care pathway for type 2 diabetes.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free